WFDC2 and ovarian cancer: For the diagnosis of ovarian cancer in patients, clinical assessments often extend beyond physical examination, which includes pelvic examination and vaginal ultrasound, to the evaluation of certain serum biomarkers, such as CA-125 and HE4.